Investing Profile

Anne Horgan

InvestorVC
Partner at Cambridge Innovation Capital
cic.vc/team/Paris, France
Photo of Anne Horgan, Partner at Cambridge Innovation Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4900 CONNECTIONS
Yale University Network
289 CONNECTIONS
Yale University Network
289 CONNECTIONS
Yale University Network
289 CONNECTIONS
Yale University Network
37 CONNECTIONS
cb
$600K - $6.0M
$3.3M
3
£225M
CompanyStageDateRound SizeTotal Raised
Complement Therapeutics
Series AApr 2023$79M
$85M
Co-investors: Max Klement (BGV (BioGeneration Ventures)), Geert-Jan Mulder (Forbion), Dmitrij Hristodorov (Forbion)
Mosaic Therapeutics
Series AApr 2023$28M
$28M
Botanical Ventures Limited
Private EquityFeb 2022$6M
$6M
Co-investors: Laurel Bowden (83North)
Postdoctoral Fellow Yale UniversityPresent
Senior Scientist, Medicinal Chemistry Cambridge Biotechnology LtdPresent
Project Development Manager Cancer Research UK (CRUK)Present
Business Development Manager Cancer Research UK (CRUK)Present
Business Development Executive Cancer Research UK (CRUK)Present
Associate - Life Sciences Sofinnova PartnersPresent
Senior Associate - Life Sciences Sofinnova PartnersPresent
Partner HotmailPresent
Partner Cambridge Innovation CapitalPresent
Yale University Diplôme d'ingénieur Chemistry (Chimie Fine et Ingénierie)
INSA Rouen Normandie Diplôme d'ingénieur Chemistry (Chimie Fine et Ingénierie)
Institut national des Sciences appliquées de Rouen Diplôme d'ingénieur Chemistry (Chimie Fine et Ingénierie)
Yale University Ph.D. Synthetic Organic Chemistry
University of Bristol Ph.D. Synthetic Organic Chemistry
Yale University Postdoc Chemistry